Biomerica, Inc. (BMRA)Â
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
BMRA Insider Trading Activity
BMRA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
About Biomerica, Inc.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Insider Activity of Biomerica, Inc.
Over the last 12 months, insiders at Biomerica, Inc. have bought $0 and sold $0 worth of Biomerica, Inc. stock.
On average, over the past 5 years, insiders at Biomerica, Inc. have bought $30,501 and sold $80,878 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 200 shares for transaction amount of $310 was made by Irani Zackary S. (Chief Executive Officer) on 2023‑05‑25.
List of Insider Buy and Sell Transactions, Biomerica, Inc.
| 2023-05-25 | Irani Zackary S. | Chief Executive Officer | 200 0.0015% | $1.55 | $310 | -34.64% | ||
| 2023-05-24 | Irani Zackary S. | Chief Executive Officer | 500 0.0037% | $1.61 | $805 | -37.65% | ||
| 2023-05-12 | Irani Zackary S. | Chief Executive Officer | 1,700 0.0132% | $1.17 | $1,989 | -6.25% | ||
| 2023-05-10 | Irani Zackary S. | Chief Executive Officer | 500 0.0038% | $1.27 | $635 | -16.00% | ||
| 2023-05-09 | Irani Zackary S. | Chief Executive Officer | 300 0.0024% | $1.39 | $417 | -18.22% | ||
| 2023-05-04 | Irani Zackary S. | Chief Executive Officer | 1,000 0.0073% | $1.36 | $1,360 | -23.19% | ||
| 2023-04-28 | Irani Zackary S. | Chief Executive Officer | 1,800 0.0135% | $1.34 | $2,412 | -18.80% | ||
| 2023-04-27 | Irani Zackary S. | Chief Executive Officer | 2,600 0.0194% | $1.31 | $3,406 | -16.92% | ||
| 2023-04-26 | Irani Zackary S. | Chief Executive Officer | 7,000 0.0528% | $1.26 | $8,820 | -12.50% | ||
| 2023-01-27 | BARBIERI ALLEN | Executive Vice Chairman | 1,538 0.0116% | $2.94 | $4,522 | -55.69% | ||
| 2023-01-26 | Coste Catherine | director | 2,190 0.016% | $2.96 | $6,482 | -57.00% | ||
| 2023-01-25 | Irani Zackary S. | Chief Executive Officer | 1,800 0.013% | $2.85 | $5,130 | -55.82% | ||
| 2023-01-24 | Irani Zackary S. | Chief Executive Officer | 2,000 0.0149% | $2.81 | $5,620 | -53.93% | ||
| 2020-10-26 | Coste Catherine | director | 9,100 0.0773% | $5.45 | $49,595 | -8.79% | ||
| 2020-04-21 | Sale | Sirgo Mark A | director | 5,000 0.0429% | $8.11 | $40,532 | -16.09% | |
| 2020-04-17 | Sale | Sirgo Mark A | director | 5,000 0.0419% | $8.07 | $40,346 | -17.46% | |
| 2018-02-09 | Irani Zackary S. | Chief Executive Officer | 500 0.0057% | $3.83 | $1,915 | -7.18% | ||
| 2018-02-02 | Irani Zackary S. | Chief Executive Officer | 1,000 0.0119% | $3.96 | $3,960 | -5.91% | ||
| 2018-01-25 | Irani Zackary S. | Chief Executive Officer | 2,039 0.0237% | $4.03 | $8,209 | -8.79% | ||
| 2018-01-25 | CANO FRANCIS | director | 8,200 0.0992% | $4.18 | $34,276 | -8.79% |
Insider Historical Profitability
| Irani Zackary S. | Chief Executive Officer | 1020560 5.5656% | $631,726.64 | 34 | 0 | <0.0001% |
| MOORE JANET TRUST DTD 8/21/98 | 635977 3.4683% | $393,669.76 | 1 | 0 | <0.0001% | |
| IRANI ZACKARY | Chief Executive Officer | 271526 1.4808% | $168,074.59 | 1 | 0 | |
| MOORE JANET | Chief Financial Officer | 140720 0.7674% | $87,105.68 | 2 | 6 | <0.0001% |
| CANO FRANCIS | director | 133736 0.7293% | $82,782.58 | 7 | 0 | <0.0001% |
| BARBIERI ALLEN | Executive Vice Chairman | 101327 0.5526% | $62,721.41 | 3 | 0 | <0.0001% |
| CAPITANIO FRANCIS E | President | 87000 0.4745% | $53,853.00 | 0 | 10 | |
| Coste Catherine | director | 43790 0.2388% | $27,106.01 | 2 | 0 | <0.0001% |
| Emerson Jane | director | 21000 0.1145% | $12,999.00 | 1 | 0 | <0.0001% |
| Sirgo Mark A | director | 8700 0.0474% | $5,385.30 | 3 | 2 | +21.92% |
BMRA Institutional Investors: Active Positions
| Increased Positions | 8 | +22.86% | 252,436 | +15.54% |
| Decreased Positions | 13 | -37.14% | 455,808 | -28.06% |
| New Positions | 5 | New | 81,576 | New |
| Sold Out Positions | 8 | Sold Out | 331,155 | Sold Out |
| Total Postitions | 30 | -14.29% | 1M | -12.52% |
BMRA Ownership Change vs Market
Institutional Investor Ownership
| Granahan Investment Management, Llc | $451.00 | 3.66% | 658,767 | +131,306 | +24.89% | 2024-12-31 |
| Vanguard Group Inc | $116.00 | 0.94% | 169,010 | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $102.00 | 0.83% | 149,081 | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $81.00 | 0.66% | 118,503 | -5,860 | -4.71% | 2024-12-31 |
| Two Sigma Securities, Llc | $38.00 | 0.31% | 55,195 | +38,254 | +225.81% | 2024-12-31 |
| State Street Corp | $26.00 | 0.21% | 37,231 | 0 | 0% | 2024-12-31 |
| Hrt Financial Lp | $25.00 | 0.2% | 36,654 | +36,654 | New | 2024-12-31 |
| Susquehanna International Group, Llp | $20.00 | 0.16% | 29,421 | -5,068 | -14.7% | 2024-12-31 |
| Newedge Advisors, Llc | $20.00 | 0.16% | 29,100 | 0 | 0% | 2024-12-31 |
| Ubs Group Ag | $16.00 | 0.13% | 23,253 | -68,439 | -74.64% | 2024-12-31 |